- Previous Close
4.0900 - Open
4.1200 - Bid 3.0200 x 100
- Ask 5.1700 x 200
- Day's Range
3.9750 - 4.2400 - 52 Week Range
1.8600 - 17.2000 - Volume
281,636 - Avg. Volume
9,104,905 - Market Cap (intraday)
33.174M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
fireflyneuro.com7
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AIFF
View MorePerformance Overview: AIFF
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AIFF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AIFF
View MoreValuation Measures
Market Cap
33.17M
Enterprise Value
33.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
67.53
Price/Book (mrq)
11.95
Enterprise Value/Revenue
69.46
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-162.14%
Return on Equity (ttm)
-832.21%
Revenue (ttm)
74k
Net Income Avi to Common (ttm)
-7.75M
Diluted EPS (ttm)
-0.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.23M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.87M